ArticleScience translational medicine2019

Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Marie-Eve Beaulieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.